Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II two-stage study of sufentanil citrate injection for analgesia in mechanically ventilated ICU patients
CTR20251953Phase 2Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sufentanil in pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Jul 2025; status: completed.
02
Drugs
sufentanil
03
Conditions
pain
Beyond the preview
Go deeper on CTR20251953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251953.